Endothelin-1--marker or mediator of vascular disease?

Endothelin-1--marker or mediator of vascular disease? Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Endothelin-1--marker or mediator of vascular disease? Abstract Text:

D J Stewart,

Endothelin-1--marker or mediator of vascular disease? Publishing Authors By Initials

DJ Stewart,

For similar cardiovascular diseases: vascular diseases research abstracts see: cardiovascular diseases: vascular diseases research

PUBMED ID PMID:

MEDLINE DATE:

Endothelin-1--marker or mediator of vascular disease? Journal Published:

PUBLICATION TYPE: Journal Article

Journal: The Canadian journal of cardiology

VOLUME: 6

Page Numbers: VIII

Journal Abbreviation:

ISSN: 1916-7075

DAY: 3

MONTH: Oct

YEAR: 1990

Endothelin-1--marker or mediator of vascular disease? Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 8510280

Endothelin-1--marker or mediator of vascular disease? Keywords Mesh Terms:

KEYWORDS: Vascular Diseases

MESH TERMS: physiopathology

Chemical & Substance for Abstract: Endothelin-1--marker or mediator of vascular disease? Information

Substance Name: Endothelins

Registry Number: 0

Grant and Affiliation Information for Endothelin-1--marker or mediator of vascular disease?

AFFILIATION: Division of Cardiology, Royal Victoria Hospital, Montreal, Quebec.

Country: CANADA

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Can J Cardiol

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Endothelin-1--marker or mediator of vascular disease? Related Publications

• A circadian rhythm in the expression of PERIOD2 protein reveals a novel SCN-controlled oscillator in the oval nucleus of the bed nucleus of the stria terminalis.
• A procedure for successful nonsurgical embryo transfer in swine.
• Amperometric determination of hydroxyamphetamine hydrobromide in a flowing stream at the glassy-carbon electrode.
• An assay for methotrexate and its metabolites in serum and urine by ion-pair high-performance liquid chromatography.
• An empirical evaluation of social support and psychological well-being in older Chinese and Korean immigrants.
• Cryoelectron microscopy and EPR analysis of engineered symmetric and polydisperse Hsp16.5 assemblies reveals determinants of polydispersity and substrate binding.
• Estimation of optimal dynamic anticoagulation regimes from observational data: a regret-based approach.
• Evidence-based medicine: A new paradigm for the teaching and practice of medicine.
• Growth factor-induced therapeutic neovascularization for ischaemic vascular disease: time for a re-evaluation?
• Influence of inbreeding on reproductive performance, ejaculate quality and testicular volume in the dog.
• Internet-based behavioral health services in health plans.
• Neuropeptide Y modulation of ethanol intake: effects of ethanol drinking history and genetic background.
• Novel functional association of serine palmitoyltransferase subunit 1-A peptide in sphingolipid metabolism with cytochrome P4501A1 transactivation and proliferative capacity of the human Glioma LN18 brain tumor cell line.
• Off-line automated sample preparation-experience in a clinical drug investigation unit.
• Overview of qualitative methods in research with diverse populations. Making research reflect the population.
• Pharmacokinetics and pharmacodynamics of intravenous epoetin alfa in children with cancer.
• Plasma and cerebrospinal fluid pharmacokinetics of erlotinib and its active metabolite OSI-420.
• Preliminary evaluation of a load-bearing BMP-2 carrier for segmental defect regeneration.
• Psychometric characteristics of a patient satisfaction instrument tailored to the concerns of African Americans.
• Psychometric characteristics of the spiritual perspective scale in pregnant African-American women.
• RM1: a reparameterization of AM1 for H, C, N, O, P, S, F, Cl, Br, and I.
• Repeatable focal seizure suppression: a rat preparation to study consequences of seizure activity based on urethane anesthesia and reversible carotid artery occlusion.
• Review of the evidence for the long-term efficacy of atypical antipsychotic agents in the treatment of patients with schizophrenia and related psychoses.
• Segmental bone regeneration using a load-bearing biodegradable carrier of bone morphogenetic protein-2.
• Specific covalent immobilization of proteins through dityrosine cross-links.
• The cell cycle inhibitory protein p21cip is not essential for maintaining beta-cell cycle arrest or beta-cell function in vivo.
• The enduring and contextual effects of physical health and depression on care-dyad mutuality.
• The laminopathies: the functional architecture of the nucleus and its contribution to disease (*).
• Topotecan central nervous system penetration is altered by a tyrosine kinase inhibitor.
• Visualization of alpha-helices in a 6-angstrom resolution cryoelectron microscopy structure of adenovirus allows refinement of capsid protein assignments.